2hdm: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:
[[Image:2hdm.jpg|left|200px]]
{{Seed}}
[[Image:2hdm.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2hdm|  PDB=2hdm  |  SCENE=  }}  
{{STRUCTURE_2hdm|  PDB=2hdm  |  SCENE=  }}  


'''Solution structure of V21C/V59C Lymphotactin/XCL1'''
===Solution structure of V21C/V59C Lymphotactin/XCL1===




==Overview==
<!--  
Chemokines adopt a conserved tertiary structure stabilized by two disulfide bridges and direct the migration of leukocytes. Lymphotactin (Ltn) is a unique chemokine in that it contains only one disulfide and exhibits large-scale structural heterogeneity. Under physiological solution conditions (37 degrees C and 150 mM NaCl), Ltn is in equilibrium between the canonical chemokine fold (Ltn10) and a distinct four-stranded beta-sheet (Ltn40). Consequently, it has not been possible to address the biological significance of each structural species independently. To stabilize the Ltn10 structure in a manner independent of specific solution conditions, Ltn variants containing a second disulfide bridge were designed. Placement of the new cysteines was based on a sequence alignment of Ltn with either the first (Ltn-CC1) or third disulfide (Ltn-CC3) in the CC chemokine, HCC-2. NMR data demonstrate that both CC1 and CC3 retain the Ltn10 chemokine structure and no longer exhibit structural rearrangement. The ability of each mutant to activate the Ltn receptor, XCR1, has been tested using an intracellular Ca2+ flux assay. These data support the conclusion that the chemokine fold of Ltn10 is responsible for receptor activation. We also examined the role of amino- and carboxyl-terminal residues in Ltn-mediated receptor activation. In contrast to previous reports, we find that the 25 residues comprising the novel C-terminal extension do not participate in receptor activation, while the native N-terminus is absolutely required for Ltn function.
The line below this paragraph, {{ABSTRACT_PUBMED_17302442}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17302442 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17302442}}


==About this Structure==
==About this Structure==
2HDM is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HDM OCA].  
2HDM is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HDM OCA].  


==Reference==
==Reference==
Line 31: Line 35:
[[Category: Nmr]]
[[Category: Nmr]]
[[Category: Xcl1]]
[[Category: Xcl1]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 06:09:28 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 05:13:47 2008''

Revision as of 02:13, 29 July 2008

File:2hdm.png

Template:STRUCTURE 2hdm

Solution structure of V21C/V59C Lymphotactin/XCL1

Template:ABSTRACT PUBMED 17302442

About this Structure

2HDM is a Single protein structure of sequence from Homo sapiens. Full experimental information is available from OCA.

Reference

An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity., Tuinstra RL, Peterson FC, Elgin ES, Pelzek AJ, Volkman BF, Biochemistry. 2007 Mar 13;46(10):2564-73. Epub 2007 Feb 16. PMID:17302442

Page seeded by OCA on Tue Jul 29 05:13:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2hdm&oldid=728537"